MedTrace Logo

Evaluation of Acute Lower Limb Ischemia

NCT05138679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2023-10-31

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the effect of different treatment modalities on clinical outcome of patients suffering from acute lower limb ischemia (ALI). Depending on clinical presentation, anatomical as well as technical considerations, different treatment options are available for revascularisation of affected limbs. Using an observational, international, multicentric study design (min. patient number of 500), the defined primary endpoint of the study, amputation-free survival 90 days after the diagnosis of ALI, will be evaluated.

Conditions

  • Acute Limb Ischemia

Interventions

PROCEDURE

Revascularization

Endovascular or surgical restoration of arterial blood flow.

PROCEDURE

Primary major amputation

Primary below- or above knee major amputation without prior revascularization.

OTHER

Best medical treatment

Conservative treatment of acute lower limb ischemia - without prior revascularization.

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Principal Investigators

  • Florian K Enzmann, MD, PhD · Department of Vascular Surgery, Medical University of Innsbruck

  • Alexandra Gratl, MD · Department of Vascular Surgery, Medical University of Innsbruck

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2023-05-31
Completion
2023-08-31

Countries

  • Austria
  • Croatia
  • France
  • Germany
  • Hungary
  • Moldova
  • Netherlands
  • Serbia
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05138679 on ClinicalTrials.gov